Professional Documents
Culture Documents
ScienceDirect
abstract
Keywords: People who inject drugs (PWID) are at an elevated risk of infection by human immuno-
Hepatitis C deficiency virus (HIV) or hepatitis C virus (HCV). In many high-income countries, needle
Human immunodeficiency virus and syringe exchange programs (NSPs) have been associated with reductions in blood-
Low- and middle-income countries borne infections. However, there is not a good understanding of the effectiveness of NSP
Needle and syringe programs in low- and middle-income countries and transitional-economy countries. A systematic
Opiate substitution programs literature review, based on the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines, was utilized to collect primary study data on the coverage of
NSP programs and the changes in HIV and HCV infection over time among PWID in low-
and middle-income and transitional countries (LMICs). We included studies that reported
laboratory measures of HIV or HCV and at least 50% coverage of the local injecting popu-
lation (either through direct use or through secondary exchange). We also included na-
tional reports of newly reported HIV cases in countries that had national level data for
PWID in conjunction with NSP scale-up and NSP implementation. Included in the review
were studies of 11 NSPs with high-coverage from Bangladesh, Brazil, China, Estonia, Iran,
Lithuania, Taiwan, Thailand, and Vietnam. In five studies, the HIV prevalence decreased
(ranged from 3% to 15%) and in three studies the HCV prevalence decreased (ranged
from 4.2% to 10.2%). In two studies, the HIV prevalence increased (ranged from 5.6% to
14.8%). The HCV incidence remained stable in one study. Of the four national reports of
newly reported HIV cases, three studies reported decreases during the expansion of the
NSP, and ranged from 30% to 93.3%; however, one national report documented an in-
crease in HIV cases (37.6%). The estimated incidence among new injectors decreased in
three studies with the reductions ranging from 11/100 person-years at risk to 16/100
person-years at risk. The data, although not fully consistent, generally support the effec-
tiveness of NSP in reducing HIV and HCV infection in LMICs. If high coverage is achieved,
NSP appears to be as effective in LMICs as in high-income countries. To identify and correct
contributing problems, additional monitoring and evaluation research is needed for NSPs
in which reductions in HIV/HCV infection among PWID are not occurring.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.
* Beth Israel Medical Center 160 Water Street FL 24, New York, NY 10038, USA.
E-mail address: DDesJarlais@chpnet.org.
1021-9498 Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
http://dx.doi.org/10.1016/j.jfda.2013.09.035
S60 j o u r n a l o f f o o d a n d d r u g a n a l y s i s 2 1 ( 2 0 1 3 ) s 5 9 es 6 1
the World Health Organization guidelines for OST pharma- ing and new programs as they emerge in LMICs to ensure that
cologic dosages. the outcomes obtained among participants are comparable to
Needle and syringe exchange programs and OST programs already established programs in high-income locations.
are an integral part of HIV harm reduction. They are associ-
ated with a reduction in overdoses, blood-borne infection references
transmission, crime and associated risky behaviors, and they
are associated with an increased quality of life. Programs
implemented on a large scale appear to be as successful in [1] Mathers BM, Degenhardt L, Phillips B, et al. Global
LMICs as they are in high-income countries. As these pro- epidemiology of injecting drug use and HIV among people
who inject drugs: a systematic review. Lancet
grams gain wider acceptance, new pilot programs will begin to
2008;372:1733e45.
emerge, which is the situation with new OST programs and
[2] Des Jarlais DC, Feelemyer JP, Modi SN, et al. High coverage
NSPs present in Eastern Europe and southeast Asia where needle/syringe programs for people who inject drugs in low
injection-related infection transmission continues to occur at and middle income countries: a systematic review. BMC Public
high levels. It will be important to continue to monitor exist- Health 2013;13:53. http://dx.doi.org/10.1186/1471-2458-13-53.